# BM-PHASE-012-I — Final Assessment

## Readiness Levels

| Level | Definition |
|---|---|
| **Internal Experimentation** | Developers can run the system, prepare invoices, test workflows |
| **Pilot Pharmacy** | A single real pharmacy using the system with pharmacist oversight |
| **Daily Use** | Pharmacist relies on the system for daily CHIFA invoicing |
| **Production (Full Deployment)** | All pharmacies, no manual fallback |

## Assessment: Internal Experimentation

### Decision: ✅ **GO**

**Justification:**
- All 630 tests pass
- EF Core writes validated on real PostgreSQL
- ReadOnly mode fully guards writes
- CircuitBreaker prevents cascade failures
- Facade provides clean API
- No regressions across 27 test files

**Conditions:**
- Must run on Test mode (not Production)
- PostgreSQL 9.3.4 32-bit limitations accepted
- Must verify CHIFA-OFFICINE can read facture rows

## Assessment: Pilot Pharmacy

### Decision: ⚠️ **GO WITH LIMITATIONS**

**Justification:**
- Invoice creation (facture + detail_fact) validated on real PG
- Option D architecture proven — BM writes only its data
- All 3 ViewModels functional
- Monitoring and audit operational

**Limitations:**
1. **TST003 root cause unknown** — bordereau visibility in CHIFA-OFFICINE not guaranteed. Option D mitigates but cannot be proven without live testing.
2. **No automated deployment** — manual installation required. Risk of misconfiguration.
3. **Superuser PostgreSQL credentials** — must create restricted role before pilot.
4. **No rollback for bordereau** — once signed/closed, only CHIFA-OFFICINE can reverse.
5. **CHIFA-OFFICINE dependency** — pilot requires CHIFA-OFFICINE installed and configured on same PostgreSQL instance.
6. **No performance benchmark** — behavior under real pharmacy load unknown.
7. **PostgreSQL 9.3 32-bit** — max ~4GB shared buffers, 100+ concurrent connections may degrade.

**Requirements for pilot:**
- Dedicated test PostgreSQL instance (not production CHIFA_OFFICINE)
- CHIFA-OFFICINE installed on pilot machine
- Pharmacist trained on Option D workflow (BM prepares, CHIFA signs/transmits)
- Restricted PG role created: `CREATE ROLE bm_pharma WITH LOGIN; GRANT INSERT ON facture, detail_fact TO bm_pharma;`
- Connection string in environment variable (not appsettings.json)
- Weekly manual review of bordereau visibility

## Assessment: Daily Use

### Decision: ❌ **NO GO**

**Justification:**
Daily use requires reliability guarantees that the current system cannot provide:

| Requirement | Status |
|---|---|
| Automated deployment | ❌ Manual only |
| CI/CD pipeline | ❌ None |
| Production-grade PostgreSQL (64-bit, v15+) | ❌ 9.3 32-bit EOL 2018 |
| Restricted database role | ❌ Superuser |
| Rollback capability | ❌ None for bordereau operations |
| CHIFA-OFFICINE independence | ❌ Critical dependency |
| Bordereau visibility guarantee | ❌ TST003 unresolved |
| Load testing (100+ invoices/day) | ❌ Not performed |
| Security audit (credentials, network) | ❌ Not performed |
| Backup/restore procedure | ❌ Not documented |
| Monitoring/alerts in production | ❌ No production monitoring |
| Support/incident response plan | ❌ Not defined |

**Recommendation:** After 3-6 months of pilot pharmacy operation with zero critical incidents, re-evaluate for Daily Use.

## Assessment: Production (Full Deployment)

### Decision: ❌ **NO GO**

**Justification:**
Production deployment requires all Daily Use requirements plus:
- High availability
- Disaster recovery
- Performance SLAs
- Security certification
- Multi-pharmacy support
- Regulatory compliance (CNAS)

None of these are addressed. The system is an early-stage prototype, not production software.

## Final Recommendation

```
Internal Experimentation:  ✅ GO            — Start now
Pilot Pharmacy:            ⚠️ GO WITH LIMITATIONS — After P0 fixes
Daily Use:                 ❌ NO GO         — Re-evaluate after pilot
Production:                ❌ NO GO         — Not in scope
```

**Next step:** Correct the 2 duplicate type definitions (compilation blockers), then proceed with pilot planning if approved.

**STOP — Phase 012 complete. Do not start Phase 013 without explicit approval.**
